COMMUNIQUÉS West-GlobeNewswire

MedWell Ai Reports Strong Q2 Revenues Of $548,315 And Provides Guidance For Full Year 2025 Exceeding $2,200,000
23/02/2026
CLEARWATER, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- via IBN -- MedWell Ai, Inc, (OTCQB: MWAI ) ("Company") is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and [...]
Liposoma Technology Strengthens Its Position as a Reference Partner for Advanced Lipid-Based Delivery Systems in Europe
23/02/2026
Bridging the Gap Between Scientific Innovation and Scalable Industrial Manufacturing Amsterdam, NORTH HOLLAND, Feb. 23, 2026 (GLOBE NEWSWIRE) -- A science-driven platform supports premium nutraceuticals, medical [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
23/02/2026
Déclaration de transactions sur actions propres Paris, France (23 février 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2025, EssilorLuxottica déclare que du 16 février 2026 [...]
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
23/02/2026
LONDON and NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Cylinder Health and Stonebrook Risk Solutions announce strategic partnership to strengthen digestive disease management
23/02/2026
The collaboration expands Stonebrook’s specialty ecosystem with a virtual-first digestive health center of excellence delivering coordinated care across the full spectrum of GI conditions CHICAGO, Feb. 23, 2026 (GLOBE [...]
Andrzej Lewandowski of Dempster Therapeutic Services Receives Prestigious 2026 ZocDoc Patient Choice Award
23/02/2026
Chicago, IL, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Dempster Therapeutic Services is proud to announce that Andrzej Lewandowski , Speech-Language Pathologist and founder, has been honored with the 2026 ZocDoc Patient Choice [...]
IBA – ACQUISITION OF OWN SHARES
23/02/2026
Louvain-la-Neuve, Belgium, February 23 rd , 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA [...]
EssilorLuxottica: Disclosure of transactions in own shares
23/02/2026
Disclosure of transactions in own shares Paris, France (February 23, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2025, EssilorLuxottica declares that [...]
Solana Company (NASDAQ: HSDT) Announces Plan for the Pacific Backbone, a High-Speed Infrastructure Buildout for Solana
23/02/2026
Deployment to be focused on Asia-Pacific region to capitalize on fast-growing wealth accumulation, cross-border payments, and institutional adoption of digital assets Expansion planned to enable Solana Company to [...]
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
23/02/2026
-- Advances reimbursement strategy in the U.S. for FemaSeed, an intended first-step infertility treatment -- ATLANTA, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making [...]
This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease
23/02/2026
DUBLIN and BRIDGEWATER, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today issued a call to [...]
Editas Medicine to Participate in Upcoming Investor Conferences
23/02/2026
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that [...]
SafeSpace Global Corporation Transitions from Pre-Revenue to Active Revenue Generation with Eight Contracted Senior Living Facility Installations
23/02/2026
Company Begins Recurring Monthly Revenue Stream in February 2026 through Deployment of AI-powered, Privacy-Aware Technology that Replaces Wearables and Loud Alarms with Proactive and Dignified Resident Safety KNOXVILLE [...]
Nucleus Upgrades Preview, The First True Glimpse of Your Future Child
23/02/2026
Couples can now model 100 potential children across rare and common diseases, offering the most complete picture of inheritance yet. NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Nucleus Genomics today introduced Preview [...]
Transactions in Connection with Share Buy-back Program
23/02/2026
Company Announcement COPENHAGEN, Denmark; February 23, 2026 – Genmab A/S (Nasdaq: GMAB). On February 17, 2026, Genmab announced the initiation of a share buy-back program to repurchase up to 342,130 shares with a [...]
Biotech Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger
23/02/2026
DENVER, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Wall Street opens to a convergence of science, scale, and strategic consolidation. From spider silk making mainstream headlines to multibillion-dollar oncology deals and [...]
Neutrolis Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors as Executive Director
23/02/2026
Dr. Dolsten, former Chief Scientific Officer and President of Worldwide Research, Development, and Medical at Pfizer, brings leadership experience spanning approximately 50 regulatory approvals and over $100 billion in [...]
Coherus Oncology to Participate in Upcoming Investor Conferences
23/02/2026
REDWOOD CITY, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS) today announced that senior management will be presenting during upcoming conferences. The presentations will be accessible [...]
INmune Bio to Detail XPro1595 Registrational Strategy in Upcoming Alzheimer’s Webinar
23/02/2026
Webinar on February 27 at 9:30 AM ET will have key opinion leaders discuss recent and upcoming clinical development of XPro1595 Boca Raton, FL, Feb. 23, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (“INmune” [...]

Pages